Article
The Good, the Bad, the Question–H19 in Hepatocellular Carcinoma
16 May 2020
Abstract excerpt
Hepatocellular carcinoma (HCC), the most common primary liver cancer, is challenging to treat due to its typical late diagnosis, mostly at an advanced stage. Therefore, there is a particular need for research in diagnostic and prognostic biomarkers and therapeutic targets for HCC. The use of long noncoding (lnc) RNAs can widen the list of novel molecular targets improving cancer therapy. In hepatocarcinogenesis,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
